Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0287 Transporter Info
Gene Name	SLC35A1
Transporter Name	CMP-sialic acid transporter
Gene ID	10559
UniProt ID	P78382

Post-Translational Modification of This DT
Overview of SLC35A1 Modification Sites with Functional and Structural Information
Sequence	M A A P R D N V T L L F K L Y C L A V M T L M A A V Y T I A L R Y T R T S D K E L Y F S T T A V C I T E V I K L L L S V G I L A K E T G S L G R F K A S L R E N V L G S P K E L L K L S V P S L V Y A V Q N N M A F L A L S N L D A A V Y Q V T Y Q L K I P C T A L C T V L M L N R T L S K L Q W V S V F M L C A G V T L V Q W K P A Q A T K V V V E Q N P L L G F G A I A I A V L C S G F A G V Y F E K V L K S S D T S L W V R N I Q M Y L S G I I V T L A G V Y L S D G A E I K E K G F F Y G Y T Y Y V W F V I F L A S V G G L Y T S V V V K Y T D N I M K G F S A A A A I V L S T I A S V M L F G L Q I T L T F A L G T L L V C V S I Y L Y G L P R Q D T T S I Q Q G E T A S K E R V I G V
PTM type	X-Phosphorylation X-Ubiquitination X: Amino Acid

Phosphorylation
Serine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC35A1			[1]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	84
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC35A1 Serine 84 has the potential to affect its expression or activity.
Threonine	3 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC35A1			[2] , [3]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	21
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC35A1 Threonine 21 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC35A1			[2] , [3]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	28
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC35A1 Threonine 28 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC35A1			[3]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	34
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC35A1 Threonine 34 has the potential to affect its expression or activity.
Tyrosine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC35A1			[2] , [3]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	27
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC35A1 Tyrosine 27 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC35A1			[3]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	33
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC35A1 Tyrosine 33 has the potential to affect its expression or activity.
Ubiquitination
Lysine	3 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC35A1			[4]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	86
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC35A1 Lysine 86 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC35A1			[5] , [6]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	272
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC35A1 Lysine 272 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC35A1			[5] , [6]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	331
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC35A1 Lysine 331 has the potential to affect its expression or activity.

References
1	A strategy for large-scale phosphoproteomics and SRM-based validation of human breast cancer tissue samples. J Proteome Res. 2012 Nov 2;11(11):5311-22.
2	In situ sample processing approach (iSPA) for comprehensive quantitative phosphoproteome analysis. J Proteome Res. 2014 Sep 5;13(9):3896-904.
3	Citric acid-assisted two-step enrichment with TiO2 enhances the separation of multi- and monophosphorylated peptides and increases phosphoprotein profiling. J Proteome Res. 2013 Jun 7;12(6):2467-76.
4	UbiSite approach for comprehensive mapping of lysine and N-terminal ubiquitination sites. Nat Struct Mol Biol. 2018 Jul;25(7):631-640.
5	Global Landscape and Dynamics of Parkin and USP30-Dependent Ubiquitylomes in iNeurons during Mitophagic Signaling. Mol Cell. 2020 Mar 5;77(5):1124-1142.e10.
6	Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. Nature. 2021 Jun;594(7862):246-252.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence